TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
Active, not recruiting · NCT03919435 · Registry updated 2026-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis | Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, cardiovascular disorder, granulomatosis with polyangiitis, immune system disorder, interstitial lung disease, lung disorder, necrotizing vasculitis, respiratory system disorder, skin disorder, skin vascular disease, vascular disorder, vasculitis | Active, not recruiting | Phase 1 / Phase 2 | 2026-09-25 | NCT03919435 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Pennsylvania | 502 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Perelman Center for Advanced Medicine | Philadelphia | United States | 12 |